Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting-Reference-Cited by-同舟云学术

Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting

Published:2014-12 Issue:6 Volume:71 Page:1167-1175
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Takeshita Junko^ORCID,Wang Shuwei,Shin Daniel B.,Callis Duffin Kristina,Krueger Gerald G.,Kalb Robert E.,Weisman Jamie D.,Sperber Brian R.,Stierstorfer Michael B.,Brod Bruce A.,Schleicher Stephen M.,Robertson Andrew D.,Linn Kristin A.,Shinohara Russell T.,Troxel Andrea B.,Van Voorhees Abby S.,Gelfand Joel M.

Publisher

Elsevier BV

Subject

Dermatology

Reference19 articles.

1. National Psoriasis Foundation. National Psoriasis Foundation Statistics. Available from: URL:http://www.psoriasis.org/research/science-of-psoriasis/statistics. Accessed September 11, 2014.

2. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions;Menter;J Am Acad Dermatol,2011

3. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris;Gniadecki;Br J Dermatol,2011

4. Biologic fatigue in psoriasis;Levin;J Dermatolog Treat,2014

5. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting;Gelfand;Arch Dermatol,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study of assessment of clinical response of methotrexate versus apremilast in chronic plaque psoriasis;Cosmoderma;2024-08-17

2. Study on the Key Genes and Molecular Mechanisms of IL-27 Promoting Keratinocytes Proliferation Based on Transcriptome Sequencing;Clinical, Cosmetic and Investigational Dermatology;2023-06

3. Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases;Advances in Therapy;2022-05-16

4. Combination Therapy with Biologic Agents;Updates in Clinical Dermatology;2022

5. Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practice;Journal of Dermatological Treatment;2021-07-30